To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Bengt Hallberg - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Bengt Hallberg

Professor

Bengt Hallberg
Professor , Avd-/sektionschef, inst
bengt.hallberg@gu.se
+46 31 786 3815
0705-665742

Postal Address: Box 440, 40530 Göteborg
Visiting Address: Medicinaregatan 9 a-b , 41390 Göteborg


Department of Medical Biochemistry and Cell biology at Institute of Biomedicine (More Information)
Box 440
405 30 Göteborg
Fax: +46 31416108
Visiting Address: Medicinaregatan 9 A-B , 413 90 Göteborg

Latest publications

Radiolabeled somatostatin analogue binding and internalization in human tumor cell lines
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
Gothenburg Cancer Meeting 2019, Gothenburg, Sweden, Conference contribution 2019
Conference contribution

Molecular targeting of various human tumor cell lines with 177Lu-octreotate
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
Annual Congress of the European Association of Nuclear Medicine , Conference contribution 2018
Conference contribution

In vitro screening for Lu-177-octreotate uptake in human tumor cell lines
Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg et al.
Cancerfondens Planeringsgrupp för Onkologisk Radionuklidterapi höstmöte 2017, Conference contribution 2017
Conference contribution

Therapeutic potential of Lu-177-octreotate for neuroblastoma – preclinical studies
Arman Romiani, Johan Spetz, Emil Schüler, Haiying Wang, Ruth H. Palmer et al.
NOPHO 35th Annual meeting 2017 19 - 23 May, Stockholm, Sweden , Conference contribution 2017
Conference contribution

Showing 1 - 36 of 36

2020

2019

Radiolabeled somatostatin analogue binding and internalization in human tumor cell lines
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
Gothenburg Cancer Meeting 2019, Gothenburg, Sweden, Conference contribution 2019
Conference contribution

2018

Molecular targeting of various human tumor cell lines with 177Lu-octreotate
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
Annual Congress of the European Association of Nuclear Medicine , Conference contribution 2018
Conference contribution

2017

In vitro screening for Lu-177-octreotate uptake in human tumor cell lines
Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg et al.
Cancerfondens Planeringsgrupp för Onkologisk Radionuklidterapi höstmöte 2017, Conference contribution 2017
Conference contribution

Therapeutic potential of Lu-177-octreotate for neuroblastoma – preclinical studies
Arman Romiani, Johan Spetz, Emil Schüler, Haiying Wang, Ruth H. Palmer et al.
NOPHO 35th Annual meeting 2017 19 - 23 May, Stockholm, Sweden , Conference contribution 2017
Conference contribution

Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation.
Jikui Guan, Yasuo Yamazaki, Damini Chand, Jesper R van Dijk, Kristina Ruuth et al.
Cancers, Journal article 2017
Journal article

Dose-response study of Lu-177-octreotate in nude mice bearing human neuroblastoma
Arman Romiani, Johan Spetz, Ruth H. Palmer, Bengt Hallberg, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

Binding and internalization of 177Lu-octreotate in human tumor cell lines of different origin
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

2016

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
Jikui Guan, E. R. Tucker, Haiying Wang, Damini Chand, L. S. Danielson et al.
DMM Disease Models and Mechanisms, Journal article 2016
Journal article

The potential of Lu-177-octreotate as a therapeutic alternative for metastatic neuroblastoma
Arman Romiani, Johan Spetz, Emil Schüler, Wan Haiying, Ruth H. Palmer et al.
62nd Annual International Meeting Radiation Research Society, Waikoloa, HI, USA, October 16-19, 2016, Conference contribution 2016
Conference contribution

Biodistribution of Lu-177-octreotate in nude mice with human neuroblastoma tumors
Arman Romiani, Johan Spetz, Emil Schüler, Wan Haiying, Ruth H. Palmer et al.
The 4th Swedish Cancer Research Meeting, Gothenburg, Sweden, November 7-8, 2016, Conference contribution 2016
Conference contribution

Comparative in vivo study of the biodistribution of Lu-177-octreotate in three neuroblastoma cell lines
Arman Romiani, Johan Spetz, Emil Schüler, Wan Haiying, Ruth H. Palmer et al.
The Swedish Cancer Society’s planning group for Oncological Radiotherapy, Uppsala, Sweden, November 24-25, 2016, Poster 2016
Poster

2015

Binding and internalization of Lu-177-octreotate in two neuroblastoma cell lines and initial biodistribution studies in animals
Arman Romiani, Johan Spetz, Emil Schüler, Wan Haiying, Ruth H. Palmer et al.
Cancerfondens planeringsgrupp för onkologisk radionuklidterapi, Höstmöte, Linköping, Sweden, November 25-27, 2015, Conference contribution 2015
Conference contribution

Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic Hypogonadism
Barbara Witek, A. El Wakil, C. Nord, U. Ahlgren, M. Eriksson et al.
Plos One, Journal article 2015
Journal article

The ALK receptor family
Ruth H. Palmer, Bengt Hallberg
Receptor Tyrosine Kinases: Family and Subfamilies, Springer, Chapter in book 2015
Chapter in book

2014

The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
Ganesh Umapathy, A. El Wakil, Barbara Witek, L. Chesler, L. Danielson et al.
Science Signaling, Journal article 2014
Journal article

2013

Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma.
Damini Chand, Yasuo Yamazaki, Kristina Ruuth, Christina Schönherr, Tommy Martinsson et al.
Disease models & mechanisms, Journal article 2013
Journal article

Jeb/Alk signalling regulates the Lame duck GLI family transcription factor in the Drosophila visceral mesoderm
D. Popichenko, F. Hugosson, C. Sjogren, M. Dogru, Y. Yamazaki et al.
Development, Journal article 2013
Journal article

Goliath family E3 ligases regulate the recycling endosome pathway via VAMP3 ubiquitylation
Y. Yamazaki, C. Schonherr, G. K. Varshney, M. Dogru, Bengt Hallberg et al.
Embo Journal, Journal article 2013
Journal article

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Bengt Hallberg, R. H. Palmer
Nature Reviews Cancer, Journal article 2013
Journal article

2012

Internalization and Down-Regulation of the ALK Receptor in Neuroblastoma Cell Lines upon Monoclonal Antibodies Treatment
P. Mazot, A. Cazes, F. Dingli, J. Degoutin, T. Irinopoulou et al.
Plos One, Journal article 2012
Journal article

The ALK(F1174L) Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
T. Berry, W. Luther, N. Bhatnagar, Y. Jamin, E. Poon et al.
Cancer Cell, Journal article 2012
Journal article

2011

Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
C. Schonherr, K. Ruuth, Y. Yamazaki, T. Eriksson, J. Christensen et al.
Biochemical Journal, Journal article 2011
Journal article

Showing 1 - 36 of 36

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?